Association of EGFR Activating Mutations With Low ERCC1 Gene Expression in Non-small Cell Lung Cancer (NSCLC): Assessment of 1,207 Patients

被引:0
|
作者
Gandara, D. [1 ]
Grimminger, P. [2 ]
Mack, P. C. [1 ]
Lara, P. N. [1 ]
Li, T. [1 ]
Danenberg, P. V. [3 ]
Danenberg, K. [4 ]
机构
[1] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
[2] Univ Cologne, Cologne, Germany
[3] Univ So Calif, Los Angeles, CA USA
[4] Response Genet Inc, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S516 / S517
页数:2
相关论文
共 50 条
  • [31] Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel
    Azuma, Koichi
    Sasada, Tetsuro
    Kawahara, Akihiko
    Takamori, Sinzo
    Hattori, Satoshi
    Ikeda, Jiro
    Itoh, Kyogo
    Yamada, Akira
    Kage, Masayoshi
    Kuwano, Michihiko
    Aizawa, Hisamichi
    LUNG CANCER, 2009, 64 (03) : 326 - 333
  • [32] ERCC1 protein expression is not associated with survival after platinum-based chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC)
    Pennell, Nathan A.
    Chirieac, Lucian R.
    El Karak, Fadi
    Lynch, Thomas J.
    Heist, Rebecca S.
    Christiani, David C.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S238 - S239
  • [33] ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis
    Jiang, Jingwei
    Liang, Xiaohua
    Zhou, Xinli
    Huang, Ruofan
    Chu, Zhaohui
    Zhan, Qiong
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (06) : 6933 - 6942
  • [34] PD-L1 Expression, EGFR Mutations and ALK Expression in Non-Small Cell Lung Cancer (NSCLC) Patients from Brazil
    Alves Da Silva, A. V.
    Tavora, F.
    Martins Neto, F.
    Oliveira, A. C. D. S.
    Alves, M.
    Carneiro, B.
    Lima, A. M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1020 - S1020
  • [35] Postoperative Adjuvant Chemotherapy for ERCC1 Positive Non-Small Cell Lung Cancer
    Ryu, Han Suk
    Xu, Xianhua
    Jheon, Sanghoon
    Lee, Jong-Seok
    Chung, Jin Haeng
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S390 - S390
  • [36] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    Park, So-Yeon
    Hong, Yun-Chul
    Kim, Jin-Hee
    Kwak, Seung-Min
    Cho, Jae-Hwa
    Lee, Hong-Lyeol
    Ryu, Jeong-Seon
    MEDICAL ONCOLOGY, 2006, 23 (04) : 489 - 498
  • [37] The prognostic value of gene expressions of ERCC1 and RRM1 in non-small cell lung cancer.
    Hasturk, Serap
    Olgunus, Ozlem
    Tuli, Abdullah
    Dundar, Ebru
    Unlu, Emine Ozgur
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [38] Association of PD-L1 expression with hotspot mutations in non-small cell lung cancer (NSCLC).
    Wan, Renping
    Zhang, Xiaoni
    Qu, Hongyue
    Li, Hui
    Li, Yingmei
    Xu, Mingyan
    Xiao, Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [39] Effect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patients
    So-Yeon Park
    Yun-Chul Hong
    Jin-Hee Kim
    Seung-Min Kwak
    Jae-Hwa Cho
    Hong-Lyeol Lee
    Jeong-Seon Ryu
    Medical Oncology, 2006, 23 : 489 - 498
  • [40] Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients
    Suk, R
    Gurubhagavatula, S
    Park, S
    Zhou, W
    Su, L
    Lynch, TJ
    Wain, JC
    Neuberg, D
    Liu, G
    Christiani, DC
    CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1534 - 1538